Zhiwei Zhang
ORCID: 0000-0002-6266-4158Also affiliated with Beijing Institute of Petrochemical Technology, University of Wisconsin–Madison, Southwest University, East China University of Science and Technology, China Pharmaceutical University, First Affiliated Hospital of Chengdu Medical College, Tongji Hospital, Huazhong University of Science and Technology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 2 papers. Top paper: “Characterization of preclinicalin vitroandin vivoADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA‐14, a new dopamine D3receptor antagonist candidate for treatment of drug addiction”.
Xiaomei Zhuang, Cuiping Yang, Zheng Li, Shan Xiong, Zhiwei Zhang +4 more
Carol Mitchell, Yurim Lee, Yimeng Dou, Zhiwei Zhang, Erica L. Fletcher +8 more